# Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy

> **NCT06365398** · PHASE4 · COMPLETED · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 180 (actual)

## Conditions studied

- Cerebral Angiography
- Heparinization

## Interventions

- **DRUG:** Heparin
- **DRUG:** Heparin Sodium Injection
- **OTHER:** No heparinization

## Key facts

- **NCT ID:** NCT06365398
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06365398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06365398, "Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06365398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*